Search Result "JAK2"
JAK2-mediated Intracellular Signaling
Journal: Current Molecular Medicine
Volume: 21 Issue: 5 Year: 2021 Page: 417-425
Author(s): Mentor Sopjani,Rifat Morina,Valdet Uka,Nguyen Thi Xuan,Miribane Dërmaku-Sopjani
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
The Relevance of JAK2 in the Regulation of Cellular Transport
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 6 Year: 2016 Page: 578-588
Author(s): Mentor Sopjani,Vjollca Konjufca,Mark Rinnerthaler,Rexhep Rexhepaj,Miribane Dërmaku-Sopjani
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
Jak2 and Reactive Oxygen Species: A Complex Relationship
Journal: Current Chemical Biology
Volume: 1 Issue: 3 Year: 2007 Page: 303-310
Author(s): Issam McDoom, Peter P. Sayeski
Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 7 Year: 2014 Page: 638-651
Author(s): Marcin Mielecki,MaÅgorzata Milner-Krawczyk,Krystyna Grzelak,Damian Mielecki,Krystiana A. Krzysko,Bogdan Lesyng,Waldemar Priebe
Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 17 Issue: 3 Year: 2017 Page: 161-166
Author(s): Habib Haybar,Elahe Khodadi,Mohammad Shahjahani,Najmaldin Saki
The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4551-4558
Author(s): R. Baskin, A. Majumder, P. P. Sayeski
Jak2 Tyrosine Kinase and Cancer: How Good Cells Get HiJAKed
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 643-650
Author(s): Michael D. Godeny, Peter P. Sayeski
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek